The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach
- PMID: 21187908
- PMCID: PMC3002995
- DOI: 10.1371/journal.pcbi.1001022
The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach
Abstract
Large-scale parallel pyrosequencing produces unprecedented quantities of sequence data. However, when generated from viral populations current mapping software is inadequate for dealing with the high levels of variation present, resulting in the potential for biased data loss. In order to apply the 454 Life Sciences' pyrosequencing system to the study of viral populations, we have developed software for the processing of highly variable sequence data. Here we demonstrate our software by analyzing two temporally sampled HIV-1 intra-patient datasets from a clinical study of maraviroc. This drug binds the CCR5 coreceptor, thus preventing HIV-1 infection of the cell. The objective is to determine viral tropism (CCR5 versus CXCR4 usage) and track the evolution of minority CXCR4-using variants that may limit the response to a maraviroc-containing treatment regimen. Five time points (two prior to treatment) were available from each patient. We first quantify the effects of divergence on initial read k-mer mapping and demonstrate the importance of utilizing population-specific template sequences in relation to the analysis of next-generation sequence data. Then, in conjunction with coreceptor prediction algorithms that infer HIV tropism, our software was used to quantify the viral population structure pre- and post-treatment. In both cases, low frequency CXCR4-using variants (2.5-15%) were detected prior to treatment. Following phylogenetic inference, these variants were observed to exist as distinct lineages that were maintained through time. Our analysis, thus confirms the role of pre-existing CXCR4-using virus in the emergence of maraviroc-insensitive HIV. The software will have utility for the study of intra-host viral diversity and evolution of other fast evolving viruses, and is available from http://www.bioinf.manchester.ac.uk/segminator/.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






Similar articles
-
Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir.J Virol. 2006 May;80(10):4909-20. doi: 10.1128/JVI.80.10.4909-4920.2006. J Virol. 2006. PMID: 16641282 Free PMC article. Clinical Trial.
-
Rescue of HIV-1 long-time archived X4 strains to escape maraviroc.Antiviral Res. 2011 Dec;92(3):488-92. doi: 10.1016/j.antiviral.2011.10.003. Epub 2011 Oct 13. Antiviral Res. 2011. PMID: 22020304
-
Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.J Virol. 2018 May 14;92(11):e00390-18. doi: 10.1128/JVI.00390-18. Print 2018 Jun 1. J Virol. 2018. PMID: 29563289 Free PMC article. Clinical Trial.
-
Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Crit Rev Microbiol. 2015;41(4):473-87. doi: 10.3109/1040841X.2013.867829. Epub 2014 Mar 17. Crit Rev Microbiol. 2015. PMID: 24635642 Review.
-
[Viral entry as therapeutic target. Current situation of entry inhibitors].Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:5-11. doi: 10.1016/s0213-005x(08)76557-1. Enferm Infecc Microbiol Clin. 2008. PMID: 19133215 Review. Spanish.
Cited by
-
Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Curr Infect Dis Rep. 2014 Apr;16(4):401. doi: 10.1007/s11908-014-0401-5. Curr Infect Dis Rep. 2014. PMID: 24585216
-
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.AIDS Res Ther. 2015 Oct 3;12:34. doi: 10.1186/s12981-015-0066-7. eCollection 2015. AIDS Res Ther. 2015. PMID: 26435727 Free PMC article.
-
A Bioinformatic Pipeline for Monitoring of the Mutational Stability of Viral Drug Targets with Deep-Sequencing Technology.Viruses. 2017 Nov 23;9(12):357. doi: 10.3390/v9120357. Viruses. 2017. PMID: 29168754 Free PMC article.
-
QuRe: software for viral quasispecies reconstruction from next-generation sequencing data.Bioinformatics. 2012 Jan 1;28(1):132-3. doi: 10.1093/bioinformatics/btr627. Epub 2011 Nov 15. Bioinformatics. 2012. PMID: 22088846 Free PMC article.
-
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.J Virol. 2021 Jan 13;95(3):e01737-20. doi: 10.1128/JVI.01737-20. Print 2021 Jan 13. J Virol. 2021. PMID: 33177204 Free PMC article.
References
-
- Shendure J, Hanlee J. Next-generation DNA sequencing. Nat Biotech. 2008;26:1135–1145. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous